Indian markets may continue with their upside momentum as cues from Asian markets are stable and Wall Street also closed in the positive territory in overnight trading. The SGX Nifty Index Future was trading higher by 28.50 points at 10,719.50.  

The stocks most likely to witness significant movement on the bourses on November 28 are Cadila Healthcare, Hinduja Ventures, Kaveri Seed Company, Yes Bank and HCL Infosystems.

Lupin has received the Establishment Inspection Report (EIR) from the US drug regulator upon completion of inspection of its facility in Tarapur, Maharashtra. The inspection was conducted between August 27 and August 31, 2018 concluded with one observation.

As part of its initiative to disinvest some of its stake in selected Central Public Sector Enterprises (CPSEs) through the ETF route Government of India’s (GOI) has come out with the fourth tranche of CPSE ETF. Let's find out if it suits your financial goals.

IIFL Holdings Limited through its subsidiary IIFL Securities plans to acquire approximately 15 per cent stake in Trendlyne, which provides an analytics platform for studying stocks. The site is popular among retail investors, analyst and advisors.

Zydus Cadila has received the final USDFA approval for Baclofen Tablets, 10mg and 20mg. The shares of the company, however fell intraday.

Alembic Pharmaceuticals has collected yet another USFDA approval, now for Temazepam Capsules. The shares of the company gained almost 3 per cent intraday. 

Following stocks are close to their 52-week low as at 12.56 p.m. on November 27, 2018.

The markets on November 27, 2018 opened flat. BSE Sensex is trading at 35,327.88, down by 26.20 points and the Nifty is trading at 10,611.50, down by 17.10 points. 

HEG announced its decision to repurchase shares and expand its graphite electrode production capacity.